BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tacke F, Wüstefeld T, Horn R, Luedde T, Srinivas Rao A, Manns MP, Trautwein C, Brabant G. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. Journal of Hepatology 2005;42:666-73. [DOI: 10.1016/j.jhep.2004.12.024] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Hung CH, Wang JH, Hu TH, Chen CH, Chang KC, Yen YH, Kuo YH, Tsai MC, Lu SN, Lee CM. Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. World J Gastroenterol 2010; 16(18): 2265-2271 [PMID: 20458764 DOI: 10.3748/wjg.v16.i18.2265] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 72] [Article Influence: 6.4] [Reference Citation Analysis]
2 Miller NE, Michel CC, Nanjee MN, Olszewski WL, Miller IP, Hazell M, Olivecrona G, Sutton P, Humphreys SM, Frayn KN. Secretion of adipokines by human adipose tissue in vivo: partitioning between capillary and lymphatic transport. American Journal of Physiology-Endocrinology and Metabolism 2011;301:E659-67. [DOI: 10.1152/ajpendo.00058.2011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
3 Kamada Y, Takehara T, Hayashi N. Adipocytokines and liver disease. J Gastroenterol. 2008;43:811-822. [PMID: 19012034 DOI: 10.1007/s00535-008-2213-6] [Cited by in Crossref: 106] [Cited by in F6Publishing: 98] [Article Influence: 7.6] [Reference Citation Analysis]
4 Siagris D, Vafiadis G, Michalaki M, Lekkou A, Starakis I, Makri M, Margaritis V, Christofidou M, Tsamandas AC, Labropoulou-Karatza C. Serum adiponectin in chronic hepatitis C and B. J Viral Hepat 2007;14:577-83. [PMID: 17650292 DOI: 10.1111/j.1365-2893.2007.00850.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
5 Durczynski A, Strzelczyk J, Wojciechowska-Durczynska K, Borkowska A, Hogendorf P, Szymanski D, Chalubinska J, Czupryniak L. Major liver resection results in early exacerbation of insulin resistance, and may be a risk factor of developing overt diabetes in the future. Surg Today 2013;43:534-8. [PMID: 22829443 DOI: 10.1007/s00595-012-0268-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Kaser S, Moschen A, Kaser A, Ludwiczek O, Ebenbichler CF, Vogel W, Jaschke W, Patsch JR, Tilg H. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis. J Intern Med. 2005;258:274-280. [PMID: 16115302 DOI: 10.1111/j.1365-2796.2005.01543.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
7 Yuan C, Zheng CT, Xu B, Yang L. Advances in understanding the role of leptin, adiponectin and resistin in liver fibrogenesis. Shijie Huaren Xiaohua Zazhi 2010; 18(2): 149-154 [DOI: 10.11569/wcjd.v18.i2.149] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Durazzo M, Niro G, Premoli A, Morello E, Rizzotto ER, Gambino R, Bo S, Musso G, Cassader M, Pagano G, Floreani A. Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression? J Gastroenterol 2009;44:476-82. [PMID: 19301087 DOI: 10.1007/s00535-009-0023-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
9 Goldmannová D, Spurná J, Krystyník O, Schovánek J, Cibičková L, Karásek D, Zadražil J. Adipocytokines and new onset diabetes mellitus after transplantation. J Appl Biomed 2018;16:247-54. [DOI: 10.1016/j.jab.2018.05.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Muñoz LE, Cordero P, Torres L, Sauceda AY, Flores JP, Segura JJ. Adipokines in a group of mexican patients with nonalcoholic steatohepatitis. Annals of Hepatology 2009;8:123-8. [DOI: 10.1016/s1665-2681(19)31790-9] [Cited by in Crossref: 14] [Article Influence: 1.1] [Reference Citation Analysis]
11 Ziai S, Elisha B, Hammana I, Tardif A, Berthiaume Y, Coderre L, Rabasa-lhoret R. Normal total and high molecular weight adiponectin levels in adults with cystic fibrosis. Journal of Cystic Fibrosis 2011;10:483-6. [DOI: 10.1016/j.jcf.2011.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
12 Sadik NA, Ahmed A, Ahmed S. The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients. Hum Exp Toxicol. 2012;31:311-321. [PMID: 22249387 DOI: 10.1177/0960327111431091] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
13 Moctezuma-Velázquez C, García-Juárez I, Soto-Solís R, Hernández-Cortés J, Torre A. Nutritional assessment and treatment of patients with liver cirrhosis. Nutrition. 2013;29:1279-1285. [PMID: 23867207 DOI: 10.1016/j.nut.2013.03.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
14 Tacke F, Zimmermann HW, Trautwein C, Schnabl B. CXCL5 plasma levels decrease in patients with chronic liver disease. J Gastroenterol Hepatol. 2011;26:523-529. [PMID: 21332547 DOI: 10.1111/j.1440-1746.2010.06436.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
15 Kalafateli M, Triantos C, Tsochatzis E, Michalaki M, Koutroumpakis E, Thomopoulos K, Kyriazopoulou V, Jelastopulu E, Burroughs A, Lambropoulou-Karatza C, Nikolopoulou V. Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis. World J Gastroenterol 2015;21:3020-9. [PMID: 25780301 DOI: 10.3748/wjg.v21.i10.3020] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
16 Tóth G, Rauh M, Nyul Z, Sulyok E, Rascher W. Serum ghrelin, adipokine and insulin levels in children with acute hepatitis. Eur J Gastroenterol Hepatol. 2009;21:739-743. [PMID: 19352196 DOI: 10.1097/MEG.0b013e32830dfcca] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
17 Kucukoglu O, Sowa JP, Mazzolini GD, Syn WK, Canbay A. Hepatokines and adipokines in NASH-related hepatocellular carcinoma. J Hepatol. 2021;74:442-457. [PMID: 33161047 DOI: 10.1016/j.jhep.2020.10.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
18 Sowka A, Dobrzyn P. Role of Perivascular Adipose Tissue-Derived Adiponectin in Vascular Homeostasis. Cells 2021;10:1485. [PMID: 34204799 DOI: 10.3390/cells10061485] [Reference Citation Analysis]
19 Alzahrani B, Iseli TJ, Hebbard LW. Non-viral causes of liver cancer: does obesity led inflammation play a role? Cancer Lett. 2014;345:223-229. [PMID: 24007864 DOI: 10.1016/j.canlet.2013.08.036] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
20 Tacke F, Trautwein C, Yagmur E, Hellerbrand C, Wiest R, Brenner DA, Schnabl B. Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course. J Gastroenterol Hepatol 2007;22:1256-64. [DOI: 10.1111/j.1440-1746.2006.04621.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
21 Corbetta S, Redaelli A, Pozzi M, Bovo G, Ratti L, Redaelli E, Pellegrini C, Beck-Peccoz P, Spada A. Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection. Eur J Clin Invest. 2011;41:898-905. [PMID: 21539538 DOI: 10.1111/j.1365-2362.2011.02498.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
22 Chen MJ, Yeh YT, Lee KT, Tsai CJ, Lee HH, Wang SN. The promoting effect of adiponectin in hepatocellular carcinoma. J Surg Oncol. 2012;106:181-187. [PMID: 22287480 DOI: 10.1002/jso.23059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
23 Yagmur E, Trautwein C, Leers MP, Gressner AM, Tacke F. Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation. Clin Biochem. 2007;40:651-655. [PMID: 17306787 DOI: 10.1016/j.clinbiochem.2006.12.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
24 Kakizaki S, Sohara N, Yamazaki Y, Horiguchi N, Kanda D, Kabeya K, Katakai K, Sato K, Takagi H, Mori M. Elevated plasma resistin concentrations in patients with liver cirrhosis. J Gastroenterol Hepatol. 2008;23:73-77. [PMID: 18171344 DOI: 10.1111/j.1440-1746.2006.04757.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
25 Claudel T, Trauner M. Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: new light on an old paradox. Hepatology 2013;57:2106-9. [PMID: 23447428 DOI: 10.1002/hep.26340] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
26 Bertolani C, Marra F. The role of adipokines in liver fibrosis. Pathophysiology. 2008;15:91-101. [PMID: 18602801 DOI: 10.1016/j.pathophys.2008.05.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 5.2] [Reference Citation Analysis]
27 Tacke F, Kanig N, En-Nia A, Kaehne T, Eberhardt CS, Shpacovitch V, Trautwein C, Mertens PR. Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease. BMC Cancer 2011;11:185. [PMID: 21595987 DOI: 10.1186/1471-2407-11-185] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
28 Tacke F, Weiskirchen R, Trautwein C. Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis. Hepatology 2008;48:1724-5; author reply 1725-6. [PMID: 18972556 DOI: 10.1002/hep.22544] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
29 Ito E, Iha K, Yoshimura T, Nakaishi K, Watabe S. Early diagnosis with ultrasensitive ELISA. Adv Clin Chem 2021;101:121-33. [PMID: 33706887 DOI: 10.1016/bs.acc.2020.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
30 Koch A, Weiskirchen R, Sanson E, Zimmermann HW, Voigt S, Dückers H, Trautwein C, Tacke F. Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation. Crit Care 2010;14:R179. [PMID: 20932285 DOI: 10.1186/cc9285] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
31 Palakshappa JA, Anderson BJ, Reilly JP, Shashaty MG, Ueno R, Wu Q, Ittner CA, Tommasini A, Dunn TG, Charles D, Kazi A, Christie JD, Meyer NJ. Low Plasma Levels of Adiponectin Do Not Explain Acute Respiratory Distress Syndrome Risk: a Prospective Cohort Study of Patients with Severe Sepsis. Crit Care 2016;20:71. [PMID: 26984771 DOI: 10.1186/s13054-016-1244-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
32 Shi RF, Lang ZW. Research progress of leptin and adiponectin in chronic liver diseases. Shijie Huaren Xiaohua Zazhi 2008; 16(29): 3303-3309 [DOI: 10.11569/wcjd.v16.i29.3303] [Reference Citation Analysis]
33 Alempijevic T, Sokic-Milutinovic A, Pavlovic Markovic A, Jesic-Vukicevic R, Milicic B, Macut D, Popovic D, Tomic D. Assessment of metabolic syndrome in patients with primary biliary cirrhosis. Wien Klin Wochenschr 2012;124:251-5. [PMID: 22531844 DOI: 10.1007/s00508-012-0162-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
34 Xu A, Wang Y, Lam KSL. Adiponectin. In: Fantuzzi G, Mazzone T, editors. Adipose Tissue and Adipokines in Health and Disease. Totowa: Humana Press; 2007. pp. 47-59. [DOI: 10.1007/978-1-59745-370-7_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Parker R, Kim SJ, Gao B. Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. Nat Rev Gastroenterol Hepatol. 2018;15:50-59. [PMID: 28930290 DOI: 10.1038/nrgastro.2017.116] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 14.6] [Reference Citation Analysis]
36 Honsawek S, Chayanupatkul M, Chongsrisawat V, Theamboonlers A, Praianantathavorn K, Udomsinprasert W, Vejchapipat P, Poovorawan Y. Serum adiponectin and transient elastography as non-invasive markers for postoperative biliary atresia. BMC Gastroenterol. 2011;11:16. [PMID: 21356120 DOI: 10.1186/1471-230x-11-16] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
37 Vairappan B. Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress. World J Hepatol 2015; 7(3): 443-459 [PMID: 25848469 DOI: 10.4254/wjh.v7.i3.443] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
38 Tsochatzis E, Papatheodoridis GV, Archimandritis AJ. The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol 2006;101:2629-40. [PMID: 16952281 DOI: 10.1111/j.1572-0241.2006.00848.x] [Cited by in Crossref: 132] [Cited by in F6Publishing: 124] [Article Influence: 8.3] [Reference Citation Analysis]
39 Ramezani-Moghadam M, Wang J, Ho V, Iseli TJ, Alzahrani B, Xu A, Van der Poorten D, Qiao L, George J, Hebbard L. Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion. J Biol Chem. 2015;290:5533-5542. [PMID: 25575598 DOI: 10.1074/jbc.m114.598011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
40 Yagmur E, Trautwein C, Gressner AM, Tacke F. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am J Gastroenterol 2006;101:1244-52. [PMID: 16771945 DOI: 10.1111/j.1572-0241.2006.00543.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
41 Balmer ML, Joneli J, Schoepfer A, Stickel F, Thormann W, Dufour JF. Significance of serum adiponectin levels in patients with chronic liver disease. Clin Sci (Lond). 2010;119:431-436. [PMID: 20524936 DOI: 10.1042/cs20100008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
42 Meng Q, Duan Z, Lin Z, Yu H, Li J, Liu Y. Serum Level of Adiponectin Correlated with Gender and Genotype in Patients with Chronic Hepatitis C. Dig Dis Sci 2009;54:1120-7. [DOI: 10.1007/s10620-008-0455-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
43 Yurtcu N, Caliskan CS, Guvey H, Celik S, Hatirnaz S, Tinelli A. Predictive and Diagnostic Value of Serum Adipokines in Pregnant Women with Intrahepatic Cholestasis. Int J Environ Res Public Health 2022;19:2254. [PMID: 35206438 DOI: 10.3390/ijerph19042254] [Reference Citation Analysis]
44 Canavesi E, Porzio M, Ruscica M, Rametta R, Macchi C, Pelusi S, Fracanzani AL, Dongiovanni P, Fargion S, Magni P, Valenti L. Increased circulating adiponectin in males with chronic HCV hepatitis. Eur J Intern Med 2015;26:635-9. [PMID: 26293833 DOI: 10.1016/j.ejim.2015.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
45 Cortez APB, Mattar RHGDM, de Azevedo RA, Fisberg M, Lederman HM, de Morais MB. Adiponectin is Increased in Pediatric Patients With Autoimmune Hepatitis Independent of Body Weight. J Pediatr Gastroenterol Nutr 2020;71:e118-23. [PMID: 32960544 DOI: 10.1097/MPG.0000000000002825] [Reference Citation Analysis]
46 Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F, Gualillo O. Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors. 2011;37:413-420. [PMID: 22038756 DOI: 10.1002/biof.185] [Cited by in Crossref: 126] [Cited by in F6Publishing: 117] [Article Influence: 11.5] [Reference Citation Analysis]
47 Hui CK, Zhang HY, Lee NP, Chan W, Yueng YH, Leung KW, Lu L, Leung N, Lo CM, Fan ST. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. J Hepatol. 2007;47:191-202. [PMID: 17462782 DOI: 10.1016/j.jhep.2007.02.023] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
48 Hung C, Lee C, Chen C, Hu T, Jiang S, Wang J, Lu S, Wang P. Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C. Liver International 2009;29:1086-93. [DOI: 10.1111/j.1478-3231.2009.01991.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
49 Siegel AB, Goyal A, Salomao M, Wang S, Lee V, Hsu C, Rodriguez R, Hershman DL, Brown RS Jr, Neugut AI, Emond J, Kato T, Samstein B, Faleck D, Karagozian R. Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients. Oncology 2015;88:57-68. [PMID: 25300295 DOI: 10.1159/000367971] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
50 Liu CJ, Chen PJ, Lai MY, Liu CH, Chen CL, Kao JH, Chen DS. High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection. Hepatol Int 2009;3:364-70. [PMID: 19669362 DOI: 10.1007/s12072-008-9111-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
51 Durazzo M, Belci P, Niro G, Collo A, Grisoglio E, Ambrogio V, Spandre M, Fontana R, Gambino R, Cassader M. Variations of serum levels of adiponectin and resistin in chronic viral hepatitis. J Endocrinol Invest. 2013;36:600-605. [PMID: 23449040 DOI: 10.3275/8883] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
52 Khattab MA, Eslam M, Aly MM, Shatat M, Hussen A, Moussa YI, Elsaghir G, Abdalhalim H, Aly A, Gaber S, Harrison SA. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4. J Clin Gastroenterol 2012;46:871-9. [PMID: 22664476 DOI: 10.1097/MCG.0b013e318256b68a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
53 Hsu CS, Liu CH, Wang CC, Tseng TC, Liu CJ, Chen CL, Chen PJ, Chen DS, Kao JH. Impact of hepatitis B virus infection on metabolic profiles and modifying factors. J Viral Hepat. 2012;19:e48-e57. [PMID: 22239526 DOI: 10.1111/j.1365-2893.2011.01535.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
54 Wang S, Yeh Y, Yu M, Wang C, Lee K. Serum adiponectin levels in cholesterol and pigment cholelithiasis. British Journal of Surgery 2006;93:981-6. [DOI: 10.1002/bjs.5395] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
55 Gatselis NK, Ntaios G, Makaritsis K, Dalekos GN. Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin Exp Med. 2014;14:121-131. [PMID: 23292294 DOI: 10.1007/s10238-012-0227-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
56 Chang MC, Chang YT, Su TC, Yang WS, Chen CL, Tien YW, Liang PC, Wei SC, Wong JM. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis. Pancreas 2007;35:16-21. [PMID: 17575540 DOI: 10.1097/MPA.0b013e3180547709] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
57 Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, Huang YZ, Honda H, Chen KD, Wang CC, Chiu KW, Jawan B, Eng HL, Goto S, Chen CL. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol. 2011;55:415-425. [PMID: 21184788 DOI: 10.1016/j.jhep.2010.11.028] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 7.8] [Reference Citation Analysis]
58 Zhang YX, Ma H. Advances in understanding the roles of leptin and adiponectin in the pathogenesis of chronic liver diseases. Shijie Huaren Xiaohua Zazhi 2010; 18(16): 1687-1693 [DOI: 10.11569/wcjd.v18.i16.1687] [Reference Citation Analysis]
59 Derbala M, Rizk N, Al-Kaabi S, Amer A, Shebl F, Al Marri A, Aigha I, Alyaesi D, Mohamed H, Aman H, Basem N. Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment. J Viral Hepat 2009;16:689-96. [PMID: 19486470 DOI: 10.1111/j.1365-2893.2009.01096.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
60 Singh L, Joshi T, Tewari D, Echeverría J, Mocan A, Sah AN, Parvanov E, Tzvetkov NT, Ma ZF, Lee YY, Poznański P, Huminiecki L, Sacharczuk M, Jóźwik A, Horbańczuk JO, Feder-Kubis J, Atanasov AG. Ethnopharmacological Applications Targeting Alcohol Abuse: Overview and Outlook. Front Pharmacol 2019;10:1593. [PMID: 32116660 DOI: 10.3389/fphar.2019.01593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
61 Tukiainen E, Kylanpaa ML, Ebeling P, Kemppainen E, Puolakkainen P, Repo H. Leptin and adiponectin levels in acute pancreatitis. Pancreas. 2006;32:211-214. [PMID: 16552343 DOI: 10.1097/01.mpa.0000202940.47837.89] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
62 Morikawa M, Naito R, Mita K, Watabe S, Nakaishi K, Yoshimura T, Miura T, Hashida S, Ito E. Subattomole detection of adiponectin in urine by ultrasensitive ELISA coupled with thio-NAD cycling. Biophys Physicobiol 2015;12:79-86. [PMID: 27493857 DOI: 10.2142/biophysico.12.0_79] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
63 Omelchenko E, Gavish D, Shargorodsky M. Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease. J Am Soc Hypertens 2014;8:376-80. [PMID: 24794207 DOI: 10.1016/j.jash.2014.03.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
64 Salman TA, Allam N, Azab GI, Shaarawy AA, Hassouna MM, El-Haddad OM. Study of adiponectin in chronic liver disease and cholestasis. Hepatol Int. 2010;4:767-774. [PMID: 21286349 DOI: 10.1007/s12072-010-9216-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
65 Mazaki-tovi M, Abood S, Segev G, Schenck P. Alterations in Adipokines in Feline Hepatic Lipidosis. J Vet Intern Med 2013;27:242-9. [DOI: 10.1111/jvim.12055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
66 Annuzzi G, Bozzetto L, Patti L, Santangelo C, Giacco R, Di Marino L, De Natale C, Masella R, Riccardi G, Rivellese AA. Type 2 diabetes mellitus is characterized by reduced postprandial adiponectin response: a possible link with diabetic postprandial dyslipidemia. Metabolism. 2010;59:567-574. [PMID: 19922965 DOI: 10.1016/j.metabol.2009.08.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
67 Panagopoulou P, Fotoulaki M, Manolitsas A, Pavlitou-tsiontsi E, Tsitouridis I, Nousia-arvanitakis S. Adiponectin and body composition in cystic fibrosis. Journal of Cystic Fibrosis 2008;7:244-51. [DOI: 10.1016/j.jcf.2007.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
68 Udomsinprasert W, Tencomnao T, Honsawek S, Anomasiri W, Vejchapipat P, Chongsrisawat V, Poovorawan Y. +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with the susceptibility to biliary atresia. World J Pediatr 2012;8:328-34. [PMID: 23151860 DOI: 10.1007/s12519-012-0377-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
69 Savvidou S. Serum Adiponectin Concentration Decreases in Higher Stages of Hepatic Fibrosis Within the Entire Clinicopathologic Spectrum of NAFLD. Journal of Clinical Gastroenterology 2010;44:230-1. [DOI: 10.1097/mcg.0b013e3181c74e25] [Cited by in Crossref: 14] [Article Influence: 1.2] [Reference Citation Analysis]
70 Polyzos SA, Kountouras J, Zavos C, Tsiaousi E. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab. 2010;12:365-383. [PMID: 20415685 DOI: 10.1111/j.1463-1326.2009.01176.x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 138] [Article Influence: 12.9] [Reference Citation Analysis]
71 Saito H, Tanaka T, Sugahara M, Tanaka S, Fukui K, Wakashima T, Nangaku M. Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet. Lab Invest 2019;99:1217-32. [PMID: 30952940 DOI: 10.1038/s41374-019-0239-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
72 Buechler C, Haberl EM, Rein-Fischboeck L, Aslanidis C. Adipokines in Liver Cirrhosis. Int J Mol Sci 2017;18:E1392. [PMID: 28661458 DOI: 10.3390/ijms18071392] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 7.2] [Reference Citation Analysis]
73 Adrych K, Smoczynski M, Stelmanska E, Korczynska J, Goyke E, Swierczynski J. Serum Adiponectin and Leptin Concentrations in Patients With Chronic Pancreatitis of Alcoholic and Nonalcoholic Origin. Pancreas 2008;36:120-4. [DOI: 10.1097/mpa.0b013e3181561187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
74 Figueroa-Juárez E, Noriega LG, Pérez-Monter C, Alemán G, Hernández-Pando R, Correa-Rotter R, Ramírez V, Tovar AR, Torre-Villalvazo I, Tovar-Palacio C. The Role of the Unfolded Protein Response on Renal Lipogenesis in C57BL/6 Mice. Biomolecules 2021;11:73. [PMID: 33430288 DOI: 10.3390/biom11010073] [Reference Citation Analysis]
75 Hayashi T, Ogawa E, Furusyo N, Murata M, Hayashi J. Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C. Infect Agent Cancer 2016;11:9. [PMID: 26913058 DOI: 10.1186/s13027-016-0056-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
76 Tacke F, Fiedler K, von Depka M, Luedde T, Hecker H, Manns MP, Ganser A, Trautwein C. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease. Liver Int. 2006;26:173-181. [PMID: 16448455 DOI: 10.1111/j.1478-3231.2005.01205.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
77 Tacke F, Fiedler K, Trautwein C. A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease. Scand J Gastroenterol. 2007;42:374-382. [PMID: 17354118 DOI: 10.1080/00365520600930826] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
78 Zhao S, Kusminski CM, Scherer PE. Adiponectin, Leptin and Cardiovascular Disorders. Circ Res 2021;128:136-49. [PMID: 33411633 DOI: 10.1161/CIRCRESAHA.120.314458] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
79 Neumeier M, Hellerbrand C, Gäbele E, Buettner R, Bollheimer C, Weigert J, Schäffler A, Weiss TS, Lichtenauer M, Schölmerich J, Buechler C. Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis. World J Gastroenterol 2006; 12(34): 5490-5494 [PMID: 17006986 DOI: 10.3748/wjg.v12.i34.5490] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
80 Li CC, Hsiang CY, Wu SL, Ho TY. Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis. Food Chem Toxicol 2012;50:1568-75. [PMID: 22386810 DOI: 10.1016/j.fct.2012.02.025] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
81 Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2009;24:233-237. [PMID: 18713296 DOI: 10.1111/j.1440-1746.2008.05548.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
82 Tazuke Y, Teitelbaum D, Wasa M, Fukuzawa M, Iiboshi Y, Fujimoto J. Parenteral Nutrition Administration Leads to Specific Alterations in the Expression of Adipocytokines and Peroxisome Proliferator-Activated Receptors in a Rat Model. JPEN J Parenter Enteral Nutr 2011;35:329-36. [DOI: 10.1177/0148607110381266] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
83 Kukla M, Kierach R, Skonieczna M, Hudy D, Dąbrowski K, Menżyk T, Derra A, Boroń D, Grabarek BO. Influence of ursodeoxycholic acid therapy on levels of fibroblast growth factor 21, adiponectin and biochemical parameters in intrahepatic cholestasis of pregnancy. Clin Exp Hepatol 2021;7:13-24. [PMID: 34027111 DOI: 10.5114/ceh.2021.104419] [Reference Citation Analysis]
84 Christou GA, Kiortsis DN. The role of adiponectin in renal physiology and development of albuminuria. J Endocrinol 2014;221:R49-61. [PMID: 24464020 DOI: 10.1530/JOE-13-0578] [Cited by in Crossref: 64] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
85 Silva T, Colombo G, Schiavon L. Adiponectin: A multitasking player in the field of liver diseases. Diabetes & Metabolism 2014;40:95-107. [DOI: 10.1016/j.diabet.2013.11.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
86 Heydari M, Cornide-Petronio ME, Jiménez-Castro MB, Peralta C. Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases? Int J Mol Sci 2020;21:E5242. [PMID: 32718097 DOI: 10.3390/ijms21155242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
87 van der Poorten D, Samer CF, Ramezani-Moghadam M, Coulter S, Kacevska M, Schrijnders D, Wu LE, McLeod D, Bugianesi E, Komuta M, Roskams T, Liddle C, Hebbard L, George J. Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause? Hepatology 2013;57:2180-8. [PMID: 22996622 DOI: 10.1002/hep.26072] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 10.9] [Reference Citation Analysis]
88 Sethna CB, Boone V, Kwok J, Jun D, Trachtman H. Adiponectin in children and young adults with focal segmental glomerulosclerosis. Pediatr Nephrol 2015;30:1977-85. [PMID: 26115618 DOI: 10.1007/s00467-015-3146-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
89 Richter J, Focke D, Ebert T, Kovacs P, Bachmann A, Lössner U, Kralisch S, Kratzsch J, Beige J, Anders M, Bast I, Blüher M, Stumvoll M, Fasshauer M. Serum levels of the adipokine progranulin depend on renal function. Diabetes Care 2013;36:410-4. [PMID: 23033238 DOI: 10.2337/dc12-0220] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
90 Marra F, Bertolani C. Adipokines in liver diseases. Hepatology 2009;50:957-69. [PMID: 19585655 DOI: 10.1002/hep.23046] [Cited by in Crossref: 330] [Cited by in F6Publishing: 315] [Article Influence: 25.4] [Reference Citation Analysis]
91 Hammana I, Malet A, Costa M, Brochiero E, Berthiaume Y, Potvin S, Chiasson JL, Coderre L, Rabasa-Lhoret R. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis. Diabetes Metab 2007;33:213-9. [PMID: 17418606 DOI: 10.1016/j.diabet.2007.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
92 Koch A, Sanson E, Voigt S, Helm A, Trautwein C, Tacke F. Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. J Crit Care 2011;26:166-74. [PMID: 20869198 DOI: 10.1016/j.jcrc.2010.07.015] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 5.0] [Reference Citation Analysis]
93 Floreani A, Variola A, Niro G, Premoli A, Baldo V, Gambino R, Musso G, Cassader M, Bo S, Ferrara F, Caroli D, Rizzotto ER, Durazzo M. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. Am J Gastroenterol 2008;103:1959-65. [PMID: 18564121 DOI: 10.1111/j.1572-0241.2008.01888.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
94 Nagy K, Nagaraju SP, Rhee CM, Mathe Z, Molnar MZ. Adipocytokines in renal transplant recipients. Clin Kidney J. 2016;9:359-373. [PMID: 27274819 DOI: 10.1093/ckj/sfv156] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]